Field | Row 1 |
---|---|
adsh | 0001683168-25-002403 |
cik | 1985554 |
name | LONDAX CORP. |
sic | 7371 |
countryba | US |
stprba | WY |
cityba | CHEYENNE |
zipba | 82001 |
bas1 | 1621 CENTRAL AVE |
bas2 | |
baph | 3727121419 |
countryma | LV |
stprma | |
cityma | RIGA |
zipma | LV-1082 |
mas1 | PUCES IELA 47 |
mas2 | |
countryinc | US |
stprinc | WY |
ein | 352807931 |
former | |
changed | |
afs | 4-NON |
wksi | 0 |
fye | 0531 |
form | 10-Q |
period | 20250228 |
fy | 2025 |
fp | Q3 |
filed | 20250410 |
accepted | 2025-04-10 10:34:00.0 |
prevrpt | 0 |
detail | 1 |
instance | londax_i10q-022825_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001683168-25-002403 | 20250228 | Accounts Payable Current | 12827.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Capitalized Contract Cost Net Current | 0.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Common Stock Shares Outstanding | 5231135.0000 | shares | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Cost Of Goods And Services Sold | 3000.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Depreciation And Amortization | 338.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Gross Profit | 25297.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Income Taxes Paid Net | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Liabilities Current | 18772.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Net Cash Provided By Used In Operating Activities | -26116.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Operating Income Loss | -3684.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Operating Income Loss | 1302.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Other Intangible Assets Net | 13819.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Payments To Develop Software | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Prepaid Expense Current | 20000.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Proceeds From Related Party Debt | 3500.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Revenues | 13165.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20231130 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20240229 | Stockholders Equity | 47686.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Stockholders Equity | 5125.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20241130 | Stockholders Equity | 61603.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20241130 | Stockholders Equity | 5231.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20250228 | Weighted Average Number Of Diluted Shares Outstanding | 5231135.0000 | shares | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Assets Noncurrent | 2961.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 13166.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Earnings Per Share Diluted | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20231130 | Net Income Loss | 11105.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
0001683168-25-002403 | 20240229 | Net Income Loss | 10123.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20241130 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
0001683168-25-002403 | 20240531 | Notes Payable Current | 14512.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Operating Expenses | 15174.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Payments To Acquire Intangible Assets | 3500.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20230531 | Proceeds From Issuance Of Common Stock | 4000.0000 | USD | 0 | us-gaap/2025 | Counterparty Name= Olegs Pavlovs; | ||
0001683168-25-002403 | 20241130 | Related Party Loan Current | 4281.0000 | USD | 0 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20241130 | Shares Outstanding | 5231135.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20240229 | Stockholders Equity | 9924.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240831 | Stockholders Equity | 5231.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20250228 | Stockholders Equity | 62905.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Stock Issued During Period Shares New Issues | 1125403.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20240229 | Weighted Average Number Of Diluted Shares Outstanding | 4391110.0000 | shares | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Additional Paid In Capital | 35703.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Cash | 1664.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1664.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Common Stock Shares Authorized | 75000000.0000 | shares | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Depreciation And Amortization | 761.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Depreciation And Amortization | 3563.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Earnings Per Share Basic | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Finite Lived Intangible Assets Net | 2587.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Income Taxes Paid Net | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Income Tax Expense Benefit | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Net Cash Provided By Used In Financing Activities | 51774.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20230831 | Net Income Loss | 2702.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20230831 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
0001683168-25-002403 | 20250228 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
0001683168-25-002403 | 20250228 | Net Income Loss | 1302.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20250228 | Payments To Develop Mobile App | 14000.0000 | USD | 3 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20230531 | Proceeds From Issuance Of Common Stock | 4000.0000 | USD | 0 | us-gaap/2025 | Counterparty Name= Director; | ||
0001683168-25-002403 | 20240229 | Proceeds From Issuance Of Common Stock | 33762.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Professional And Contract Services Expense | 2076.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Project In Progress | 37000.0000 | USD | 3 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20240531 | Retained Earnings Accumulated Deficit | -2081.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20230531 | Shares Outstanding | 4000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20231130 | Shares Outstanding | 4000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20230531 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20230831 | Stockholders Equity | 6503.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Stockholders Equity | 5231.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20250228 | Stockholders Equity | 35703.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20230531 | Stock Issued During Period Shares New Issues | 4000000.0000 | shares | 0 | us-gaap/2025 | Counterparty Name= Olegs Pavlovs; | ||
0001683168-25-002403 | 20250228 | Common Stock Shares Issued | 5231135.0000 | shares | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Common Stock Value | 5231.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | General And Administrative Expense | 8916.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Interest Paid Net | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Interest Paid Net | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
0001683168-25-002403 | 20240229 | Net Income Loss | -3684.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240831 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
0001683168-25-002403 | 20240831 | Net Income Loss | 10297.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20250228 | Net Income Loss | 1302.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Other Intangible Assets Net | 0.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Payments To Develop Software | 28828.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Professional And Contract Services Expense | 3115.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20230831 | Shares Outstanding | 4000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20230831 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20250228 | Stockholders Equity | 21971.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240229 | Stock Issued During Period Value New Issues | 33762.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Assets Current | 33166.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Capitalized Contract Cost Net Noncurrent | 0.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 26158.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Cost Of Goods And Services Sold | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20241130 | Net Income Loss | 12453.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Gross Profit | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Gross Profit | 54410.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Increase Decrease In Accounts Payable | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Increase Decrease In Accounts Payable | 12827.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Net Cash Provided By Used In Financing Activities | -14491.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Net Cash Provided By Used In Investing Activities | -3500.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Net Cash Provided By Used In Investing Activities | -50528.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20231130 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
0001683168-25-002403 | 20240831 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
0001683168-25-002403 | 20250228 | Operating Expenses | 8863.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Operating Expenses | 30358.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240131 | Proceeds From Issuance Of Common Stock | 21156.0000 | USD | 0 | us-gaap/2025 | Transaction Type= Consideration; | ||
0001683168-25-002403 | 20240229 | Revenues | 25297.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20230831 | Stockholders Equity | 2503.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240531 | Stockholders Equity | 38853.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240831 | Stockholders Equity | 35703.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20240229 | Stock Issued During Period Value New Issues | 32637.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20240229 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
0001683168-25-002403 | 20250228 | Weighted Average Number Of Diluted Shares Outstanding | 5231135.0000 | shares | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Assets Noncurrent | 46847.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Accounts Payable Current | 0.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Assets | 80013.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Capitalized Contract Cost Net Current | 33000.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Cash | 13166.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20230531 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4000.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 22158.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Common Stock Shares Outstanding | 5231135.0000 | shares | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Cost Of Goods And Services Sold | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Depreciation And Amortization | 6642.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Earnings Per Share Diluted | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Finite Lived Intangible Assets Net | 8771.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | General And Administrative Expense | 231.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | General And Administrative Expense | 252.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | General And Administrative Expense | 3224.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Gross Profit | 10165.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Liabilities And Stockholders Equity | 57625.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Liabilities Current | 17108.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Net Cash Provided By Used In Operating Activities | 76521.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20230831 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
0001683168-25-002403 | 20250228 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
0001683168-25-002403 | 20250228 | Net Income Loss | 24052.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Notes Payable Current | 0.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Operating Expenses | 3684.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Payments To Develop Mobile App | 0.0000 | USD | 3 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20240531 | Prepaid Expense Current | 20000.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Proceeds From Related Party Debt | 21.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Proceeds From Repayments Of Notes Payable | 14512.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Proceeds From Repayments Of Notes Payable | -14512.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Property Plant And Equipment Net | 234.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Related Party Loan Current | 4260.0000 | USD | 0 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20240229 | Revenues | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Shares Outstanding | 5231135.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20250228 | Shares Outstanding | 5231135.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20230531 | Stock Issued During Period Shares New Issues | 4000000.0000 | shares | 0 | us-gaap/2025 | Counterparty Name= Director; | ||
0001683168-25-002403 | 20240131 | Stock Issued During Period Shares New Issues | 705203.0000 | shares | 0 | us-gaap/2025 | Transaction Type= Consideration; | ||
0001683168-25-002403 | 20240229 | Stock Issued During Period Shares New Issues | 420200.0000 | shares | 0 | us-gaap/2025 | Transaction Type= Consideration; | ||
0001683168-25-002403 | 20240229 | Weighted Average Number Of Shares Outstanding Basic | 4391110.0000 | shares | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Weighted Average Number Of Shares Outstanding Basic | 5231135.0000 | shares | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Additional Paid In Capital | 35703.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Assets | 57625.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Assets Current | 54664.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 11502.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Common Stock Shares Authorized | 75000000.0000 | shares | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Cost Of Goods And Services Sold | 12000.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Earnings Per Share Basic | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Income Tax Expense Benefit | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20231130 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
0001683168-25-002403 | 20240229 | Net Income Loss | -3684.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20241130 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
0001683168-25-002403 | 20250228 | Operating Income Loss | 24052.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Payments To Acquire Intangible Assets | 7700.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Proceeds From Issuance Of Common Stock | 12606.0000 | USD | 0 | us-gaap/2025 | Transaction Type= Consideration; | ||
0001683168-25-002403 | 20250228 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Professional And Contract Services Expense | 14161.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Related Party Loan Current | 4281.0000 | USD | 0 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20230531 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20231130 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20231130 | Stockholders Equity | 13608.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240531 | Stockholders Equity | -2081.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240831 | Stockholders Equity | 49150.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240831 | Stockholders Equity | 8216.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20241130 | Stockholders Equity | 35703.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20241130 | Stockholders Equity | 20669.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20250228 | Stockholders Equity | 5231.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20240229 | Weighted Average Number Of Shares Outstanding Basic | 4130370.0000 | shares | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Weighted Average Number Of Shares Outstanding Basic | 5231135.0000 | shares | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Capitalized Contract Cost Net Noncurrent | 24023.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Common Stock Shares Issued | 5231135.0000 | shares | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240531 | Common Stock Value | 5231.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Liabilities And Stockholders Equity | 80013.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20230831 | Net Income Loss | 2702.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20231130 | Net Income Loss | 11105.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240831 | Net Income Loss | 10297.0000 | USD | 1 | us-gaap/2025 | |||
0001683168-25-002403 | 20241130 | Net Income Loss | 12453.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20240229 | Operating Income Loss | 10123.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Professional And Contract Services Expense | 14800.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Project In Progress | -33000.0000 | USD | 3 | 0001683168-25-002403 | |||
0001683168-25-002403 | 20240531 | Property Plant And Equipment Net | 374.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Retained Earnings Accumulated Deficit | 21971.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20250228 | Revenues | 66410.0000 | USD | 3 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Shares Outstanding | 5125403.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20240831 | Shares Outstanding | 5231135.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20230531 | Stockholders Equity | 3801.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20230531 | Stockholders Equity | -199.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001683168-25-002403 | 20230831 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20231130 | Stockholders Equity | 17608.0000 | USD | 0 | us-gaap/2025 | |||
0001683168-25-002403 | 20240229 | Stockholders Equity | 32637.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20240531 | Stockholders Equity | 35703.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001683168-25-002403 | 20240229 | Stock Issued During Period Value New Issues | 1125.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001683168-25-002403 | 20240229 | Weighted Average Number Of Diluted Shares Outstanding | 4130370.0000 | shares | 3 | us-gaap/2025 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Payments To Develop Mobile App | 0001683168-25-002403 | 1 | 0 | monetary | D | C | PaymentsToDevelopMobileApp | |
Related Party Loan Current | 0001683168-25-002403 | 1 | 0 | monetary | I | C | Related Party Loan | |
Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Proceeds From Repayments Of Notes Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from (Repayments of) Notes Payable | Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation. |
Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Finite Lived Intangible Assets Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Payments To Acquire Intangible Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Intangible Assets | The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. |
Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Proceeds From Related Party Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Capitalized Contract Cost Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Capitalized Contract Cost, Net, Current | Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current. |
Capitalized Contract Cost Net Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Capitalized Contract Cost, Net, Noncurrent | Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent. |
Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Other Intangible Assets Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Intangible Assets, Net | Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other. |
Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
Depreciation And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Professional And Contract Services Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Professional and Contract Services Expense | Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support. |
Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
Cash | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Interest Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activity | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
Prepaid Expense Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Project In Progress | 0001683168-25-002403 | 1 | 0 | monetary | D | C | ProjectInProgress | |
Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Cost Of Goods And Services Sold | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Product and Service Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
Payments To Develop Software | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Develop Software | The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization. |
Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Income Taxes Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001683168-25-002403 | 2 | 1 | BS | 0 | H | Cash | us-gaap/2025 | Cash | 0 |
0001683168-25-002403 | 2 | 2 | BS | 0 | H | Prepaid Expense Current | us-gaap/2025 | Prepaid Expenses | 0 |
0001683168-25-002403 | 2 | 3 | BS | 0 | H | Capitalized Contract Cost Net Current | us-gaap/2025 | Software in Development | 0 |
0001683168-25-002403 | 2 | 4 | BS | 0 | H | Assets Current | us-gaap/2025 | Total Current Assets | 0 |
0001683168-25-002403 | 2 | 5 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Fixed Assets, Net | 0 |
0001683168-25-002403 | 2 | 6 | BS | 0 | H | Other Intangible Assets Net | us-gaap/2025 | Mobile App, Net | 0 |
0001683168-25-002403 | 2 | 7 | BS | 0 | H | Capitalized Contract Cost Net Noncurrent | us-gaap/2025 | Software Development Costs, Net | 0 |
0001683168-25-002403 | 2 | 8 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2025 | Website, Net | 0 |
0001683168-25-002403 | 2 | 9 | BS | 0 | H | Assets Noncurrent | us-gaap/2025 | Total Other Assets | 0 |
0001683168-25-002403 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2025 | Total Assets | 0 |
0001683168-25-002403 | 2 | 11 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts Payable | 0 |
0001683168-25-002403 | 2 | 12 | BS | 0 | H | Notes Payable Current | us-gaap/2025 | Notes Payable | 0 |
0001683168-25-002403 | 2 | 13 | BS | 0 | H | Related Party Loan Current | 0001683168-25-002403 | Related Party Loan | 0 |
0001683168-25-002403 | 2 | 14 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total Current Liabilities | 0 |
0001683168-25-002403 | 2 | 15 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common Stock, $0.001 par value, 75,000,000 shares authorized; 5,231,135 and 5,231,135 shares issued and outstanding, respectively | 0 |
0001683168-25-002403 | 2 | 16 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional Paid-in Capital | 0 |
0001683168-25-002403 | 2 | 17 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated Income (Deficit) | 0 |
0001683168-25-002403 | 2 | 18 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total Stockholders Equity | 0 |
0001683168-25-002403 | 2 | 19 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total Liabilities and Stockholders Equity | 0 |
0001683168-25-002403 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common Stock, Par or Stated Value Per Share | 0 |
0001683168-25-002403 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common Stock, Shares Authorized | 0 |
0001683168-25-002403 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common Stock, Shares, Issued | 0 |
0001683168-25-002403 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common Stock, Shares, Outstanding | 0 |
0001683168-25-002403 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2025 | REVENUES | 0 |
0001683168-25-002403 | 4 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2025 | Cost of sales | 0 |
0001683168-25-002403 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2025 | GROSS PROFIT | 0 |
0001683168-25-002403 | 4 | 4 | IS | 0 | H | Depreciation And Amortization | us-gaap/2025 | Amortization and Depreciation Expense | 0 |
0001683168-25-002403 | 4 | 5 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and Administrative Expenses | 0 |
0001683168-25-002403 | 4 | 6 | IS | 0 | H | Professional And Contract Services Expense | us-gaap/2025 | Professional Fees | 0 |
0001683168-25-002403 | 4 | 7 | IS | 0 | H | Operating Expenses | us-gaap/2025 | TOTAL OPERATING EXPENSES | 0 |
0001683168-25-002403 | 4 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | NET INCOME /(LOSS) FROM OPERATIONS | 0 |
0001683168-25-002403 | 4 | 9 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | PROVISION FOR INCOME TAXES | 0 |
0001683168-25-002403 | 4 | 10 | IS | 0 | H | Net Income Loss | us-gaap/2025 | NET INCOME /(LOSS) | 0 |
0001683168-25-002403 | 5 | 1 | IS | 1 | H | Earnings Per Share Basic | us-gaap/2025 | Earnings Per Share, Basic | 0 |
0001683168-25-002403 | 5 | 2 | IS | 1 | H | Earnings Per Share Diluted | us-gaap/2025 | Earnings Per Share, Diluted | 0 |
0001683168-25-002403 | 5 | 3 | IS | 1 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted Average Number of Shares Outstanding, Basic | 0 |
0001683168-25-002403 | 5 | 4 | IS | 1 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted Average Number of Shares Outstanding, Diluted | 0 |
0001683168-25-002403 | 6 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Beginning balance, value | 0 |
0001683168-25-002403 | 6 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Shares, Outstanding, Beginning Balance | 0 |
0001683168-25-002403 | 6 | 10 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net Income | 0 |
0001683168-25-002403 | 6 | 11 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Common stock issued for cash | 0 |
0001683168-25-002403 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Stock Issued During Period, Shares, New Issues | 0 |
0001683168-25-002403 | 6 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Ending balance, value | 0 |
0001683168-25-002403 | 6 | 14 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Shares, Outstanding, Ending Balance | 0 |
0001683168-25-002403 | 7 | 1 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net Income (Loss) | 0 |
0001683168-25-002403 | 7 | 2 | CF | 0 | H | Depreciation And Amortization | us-gaap/2025 | Amortization and Depreciation Expense | 0 |
0001683168-25-002403 | 7 | 3 | CF | 0 | H | Project In Progress | 0001683168-25-002403 | Project-In-Progress | 1 |
0001683168-25-002403 | 7 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts Payable | 0 |
0001683168-25-002403 | 7 | 5 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | CASH FLOWS USED IN OPERATING ACTIVITIES | 0 |
0001683168-25-002403 | 7 | 6 | CF | 0 | H | Payments To Develop Software | us-gaap/2025 | Software Development Costs | 1 |
0001683168-25-002403 | 7 | 7 | CF | 0 | H | Payments To Develop Mobile App | 0001683168-25-002403 | Mobile App | 1 |
0001683168-25-002403 | 7 | 8 | CF | 0 | H | Payments To Acquire Intangible Assets | us-gaap/2025 | Website | 1 |
0001683168-25-002403 | 7 | 9 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | CASH FLOWS PROVIDED BY INVESTING ACTIVITIES | 0 |
0001683168-25-002403 | 7 | 10 | CF | 0 | H | Proceeds From Repayments Of Notes Payable | us-gaap/2025 | Notes Payable | 0 |
0001683168-25-002403 | 7 | 11 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from the Issuance of Common Stock | 0 |
0001683168-25-002403 | 7 | 12 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2025 | Related Party Loan | 0 |
0001683168-25-002403 | 7 | 13 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | CASH FLOWS PROVIDED BY FINANCING ACTIVITIES | 0 |
0001683168-25-002403 | 7 | 14 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net increase (decrease) in cash and equivalents | 0 |
0001683168-25-002403 | 7 | 15 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and equivalents at beginning of the period | 0 |
0001683168-25-002403 | 7 | 16 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and equivalents at end of the period | 0 |
0001683168-25-002403 | 7 | 18 | CF | 0 | H | Interest Paid Net | us-gaap/2025 | Interest | 0 |
0001683168-25-002403 | 7 | 19 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2025 | Taxes | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |